FC1C=C(C=CC=1)C([NH:7][C:8]1[CH:13]=[CH:12][C:11]([CH3:14])=[C:10]([C:15]2[CH:16]=[C:17]3[C:21](=[CH:22][CH:23]=2)[NH:20][C:19]2[N:24]=[CH:25][N:26]=[CH:27][C:18]3=2)[CH:9]=1)=O.O1CCOCC1.[OH-].[Na+].CCOC(C)=O>CC(O)C.C(Cl)(Cl)Cl>[CH3:14][C:11]1[CH:12]=[CH:13][C:8]([NH2:7])=[CH:9][C:10]=1[C:15]1[CH:16]=[C:17]2[C:21](=[CH:22][CH:23]=1)[NH:20][C:19]1[N:24]=[CH:25][N:26]=[CH:27][C:18]2=1To 3-fluoro-N-[4-methyl-3-(9H-pyrimido[4,5-b]indol-6-yl)phenyl]benzamide (205 mg, 0.517 mmol) was added 1,4-dioxane (3.1 mL) and aqueous sodium hydroxide (3.8M, 2.72 mL, 10.0 mmol) followed by solid sodium hydroxide (1.67 g, 41.7 mmol). The reaction was heated to 100° C. until LCMS indicated complete hydrolysis, typically 16-24 hours. The reaction was cooled to ambient temperature and partitioned between water and EtOAc, which resulted in the formation of solids. These solids were dissolved through successive extractions with EtOAc and 3:1 CHCl3:IPA. The organic phases were separately washed with water and saturated aqueous NaCl, then dried (MgSO4), the dried solutions were combined and evaporated to dryness to leave the crude product (133 mg, 93.8%). 1H NMR (300 MHz, DMSO): δ 12.33 (bs, 1H), 9.46 (s, 1H), 8.91 (s, 1H), 8.16 (s, 1H), 7.57 (d, 1H), 7.44 (dd, 1H), 6.94 (d, 1H), 6.4-6.6 (m, 2H), 5.00 bs, 2H), 2.08 (s, 3H). MS (EI) m/z=275 (M+H).